AOX1 Antibodies

Santa Cruz Biotechnology provides a broad selection of AOX1 monoclonal antibodies for investigating aldehyde oxidase 1 protein function. AOX1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Aldehyde oxidase 1 is an essential enzyme that metabolizes aldehydes and facilitates detoxification processes within the body. AOX1 plays a significant role in the biosynthesis of bioactive molecules and has been linked to various metabolic pathways. Research has shown that AOX1 activity influences several physiological processes and may be altered in certain disease states. Understanding AOX1 function and regulation continues to be an active area of investigation in metabolic research. Studying AOX1 expression and activity patterns can reveal new insights into metabolic disorders and potential therapeutic approaches. Recent findings have highlighted the importance of AOX1 in drug metabolism and xenobiotic transformation. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of AOX1 biology and its implications in human health and disease.